European Commission Approves Merck’s CAPVAXIVE for Pneumococcal Disease in Adults

Read more

Character Biosciences Raises $93M Series B for Eye Disease Precision Medicine

Read more

FDA Grants Fast Track to Chlamydia Vaccine Candidate

Read more

Novo Holdings Joins €23M Series A for Tribune Therapeutics to Advance Anti-Fibrotic Therapies

Read more

MSD Secures Exclusive License for HRS-5346 from Jiangsu Hengrui

Read more

United Laboratories & Novo Nordisk Announce Exclusive License for UBT251

Read more

GSK, UK DRI, HDR UK Launch Dementia Research Initiative

Read more

FDA Approves Blujepa for Uncomplicated UTIs in Women and Kids 12+

Read more

EMA Accepts GSK’s Nucala COPD Expansion Review

Read more

FDA Approves Alnylam’s AMVUTTRA for ATTR-CM

Read more